At my age 2,3 years growth is more what I hope to see. I hope to see a pps of 7$+ in 24 months or so (following FY 2023 financials). For that however the company will have to show they can sell (let's se what Q4 did generate (for me anything under CDN $3,5M would be bad news)
On November 29th Else Nutrition (TSXV: BABY) announced its third quarter financial results. The company reported revenues of $1.17 million, up from $1.1 million last quarter, while gross profits dropped from $0.27 million last quarter to $0.06 million this quarter. The company also saw a larger operating loss than last quarter at $4.55 million.
Canaccord Genuity lowered their 12-month price target to C$4.00 from C$5.75 and reiterated their speculative buy rating on the stock, saying that another quarter of misses has them reducing their estimates.
For the results, Else Nutrition came in roughly 31% below Canaccord’s revenue estimate and 74% below their gross profit estimate, while the companies reported ($4.0) million in adjusted EBITDA came in line with Canaccord’s estimates.
Canaccord says that the revenue miss was primarily driven by weaker than expected formula sales. The company reported segment revenues of $0.9 million versus Canaccord’s estimates of $1.4 million. The companies revenue from baby feeding accessories and baby snacks came in line with their expectations.